Antagonistic Activity of Nocardia brasiliensis PTCC 1422 Against Isolated Enterobacteriaceae from Urinary Tract Infections
- 26 February 2016
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 8 (1) , 41-45
Abstract
The main drawback of current antibiotic therapies is the emergence and rapid increase in antibiotic resistance. Nocardiae are aerobic, Gram-positive, catalase-positive, non-motile actinomycetes. Nocardia brasiliensis was reported as antibiotic producer. The purpose of the study was to determine antibacterial activity of N. brasiliensis PTCC 1422 against isolated Enterobacteriaceae from urinary tract infections (UTIs). The common bacteria from UTIs were isolated from hospital samples. Antimicrobial susceptibility test was performed for the isolated pathogens using Kirby–Bauer disk diffusion method according to clinical and Laboratory Standards Institute guideline. Antagonistic activity of N. brasiliensis PTCC 1422 was examined with well diffusion methods. Supernatant of N. brasiliensis PTCC 1422 by submerged culture was analyzed with gas chromatography–mass spectrometry. Isolated strains included Escherichia coli, Klebsiella pneumoniae, Serratia marcescens and Proteus mirabilis. The most common pathogen isolated was E. coli (72.5 %). Bacterial isolates revealed the presence of high levels of antimicrobial resistances to ceftriaxone and low levels of resistance to cephalexin. Supernatant of N. brasiliensis PTCC 1422 showed antibacterial activity against all of the isolated microorganisms in well diffusion method. The antibiotic resistance among the uropathogens is an evolving process, so a routine surveillance to monitor the etiologic agents of UTI and the resistance pattern should be carried out timely to choose the most effective empirical treatment by the physicians. Our present investigation indicates that the substances present in the N. brasiliensis PTCC 1422 could be used to inhibit the growth of human pathogen. Antibacterial resistance among bacterial uropathogen is an evolving process. Therefore, in the field on the need of re-evaluation of empirical treatment of UTIs, our present. The study has demonstrated that N. brasiliensis PTCC 1422 has a high potential for the treatment of UTIs.Keywords
This publication has 15 references indexed in Scilit:
- Isolation and Identification of Actinomycetes from Termite’s Gut against Human PathogenAsian Journal of Animal and Veterinary Advances, 2011
- Metabolic Engineering of Nocardia sp. CS682 for Enhanced Production of Nargenicin A1Applied Biochemistry and Biotechnology, 2011
- Infections with Extended-Spectrum β-Lactamase-Producing EnterobacteriaceaeDrugs, 2010
- Endophytic Actinomycetes from Azadirachta indica A. Juss.: Isolation, Diversity, and Anti-microbial ActivityMicrobial Ecology, 2008
- Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasivenessJournal of Antimicrobial Chemotherapy, 2007
- Transvalencin Z, a New Antimicrobial Compound with Salicylic Acid Residue from Nocardia transvalensis IFM 10065The Journal of Antibiotics, 2006
- Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the communityJournal of Antimicrobial Chemotherapy, 2005
- Brasilicardins B–D, new tricyclic terpernoids from actinomycete Nocardia brasiliensisBioorganic & Medicinal Chemistry, 2004
- Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Design of optimum response surface experiments for adsorption of direct dye on chitosanBioprocess and Biosystems Engineering, 2000